Community pharmacies face Adderall supply disruptions

Many community pharmacists are struggling to stock Adderall amid supply disruptions and high demand for the attention-deficit/hyperactivity disorder treatment, Bloomberg reported Aug. 18. 

Advertisement

Among 358 community pharmacy leaders polled between July 25 and Aug. 5, 64 percent said brand name and generic versions of Adderall were on backorder, a survey from the National Community Pharmacists Association found.

In late July, Teva Pharmaceuticals told Blomberg it was experiencing “supply disruptions” of the drug. The company, which is the largest Adderall supplier in the U.S., said it expects supply levels to normalize in the next few weeks. 

In 2021, the U.S. saw 41 million prescriptions for Adderall, marking a 10 percent increase from the year prior, according to data from Symphony Health cited by Bloomberg.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.